Identification and temporal trends of patients with neuromyelitis optica spectrum disorder in a US insurance claims database

CONCLUSIONS: Among patients likely to have NMOSD, low AQP4-IgG testing rates, IST use, frequent MS diagnosis claims and DMT use highlight the need for a diagnostic algorithm and timely treatment of NMOSD.PMID:33879033 | DOI:10.1080/13696998.2021.1917421

Source: Journal of Medical Economics - April 21, 2021 Category: Health Management Authors: Alex Exuzides Ning Wu Daniel Sheinson Carlos Flores Avile Cristina Costantino Paris Sidiropoulos Source Type: research